Similar articles

• [Erythrocyte lipids in diabetes mellitus with vascular involvement].

  Kasimova GM, Mirtalipov DT, Abidov AA, Akbarov ZS. Kasimova GM, et al. Vopr Med Khim. 1989 May-Jun;35(3):42-7. Vopr Med Khim. 1989. PMID: 2773383 Russian.
• [Study of lipid metabolism in diabetics with retinal angiopathies following the administration of triiodothyronine].

  Prokop V, Musil F, Musilová Z, Tvrzký J, Kozina M. Prokop V, et al. Cas Lek Cesk. 1970 Aug;109(34):798-800. Cas Lek Cesk. 1970. PMID: 5455599 Czech. No abstract available.
• [Serum lipids and diabetic control with special reference to angiopathy (author's transl)].

  Morimoto M. Morimoto M. Rinsho Byori. 1975 Jan;23(1):1-6. Rinsho Byori. 1975. PMID: 1168267 Japanese. No abstract available.
• [Measurement of treatment efficacy in diabetes: effect of atherosclerosis prevention and general effects].

  Czech A, Szczeklik-Kumala Z. Czech A, et al. Pol Merkur Lekarski. 1997 Jan;2(7):49-51. Pol Merkur Lekarski. 1997. PMID: 9296902 Review. Polish.
• Management of hyperlipidemia in diabetes.

  Vinik AI, O'Brian JT, Georges LP, Leichter SB, Janin Y. Vinik AI, et al. Compr Ther. 1995 Oct;21(10):602-9. Compr Ther. 1995. PMID: 8565431 Review. No abstract available.